Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Viva Gold Reports Strong Initial Assay Results for its Fall 2024 Drill Program (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Else Nutrition Holdings Inc T.BABY

Alternate Symbol(s):  BABYF | T.BABY.WT.A

Farm Products
Else Nutrition Holdings Inc is an Israel-based company active in field of food manufacturing. The Company focuses on research, development, manufacturing, marketing and sale of innovative plant-based food and nutrition products and also maintain feeding accessories products to infants and dried food snacks.


TSX:BABY - Post by User

Else Nutrition Holdings Inc > No market LOVE But
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(139)
•••
Post by PaperBoi222on Jun 04, 2023 11:14am
390 Views
Post# 35479121

No market LOVE But

No market LOVE ButElse has really stepped their game up and continues to open the distribution channel for future sales
and growth to the bottom line.

SP has been in the pattern for several months.

Is this the right time for investors to start cost averaging into a position?

I think recent developments add some justification.

What a great developing company and story of health


Cheers

PB
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities